| 1 |
25982012 | Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases. | 2015 Jul |
2 |
| 2 |
21795074 | Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line. | 2013 Aug |
1 |
| 3 |
23277288 | PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors. | 2013 Mar 12 |
1 |
| 4 |
23446814 | Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib. | 2013 Sep |
12 |
| 5 |
19495754 | Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences. | 2010 Jan |
3 |
| 6 |
17912240 | ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. | 2007 Oct 8 |
7 |